Fund Holdings — Cormorant Asset Management, LP

Total Portfolio Value:
$1.32B
Total Bought:
$153.90M
Total Sold:
$291.05M
Net Transaction:
-$137.15M
Notable People:
Bihua Chen, Cormorant Asset Management Gp,
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MoonLake ImmunotherapeuticsCL A(MLTX)8,494,1518,494,1510$459.96M$331.87M25.13%-$128.09M
Edgewise Therapeutics, Inc.(EWTX)3,406,5344,101,992+695,458$90.95M$90.24M6.83%-$710.6K
BridgeBio Pharma, Inc.(BBIO)1,600,0002,000,000+400,000$43.90M$69.14M5.23%+$25.24M
Arcellx Inc
COMMON STOCK
1,300,0001,050,000-250,000$99.70M$68.88M5.22%-$30.82M
Praxis Precision Medicines, Inc.(PRAX)1,693,2191,745,000+51,781$130.31M$66.08M5.00%-$64.23M
Newamsterdam Pharma Company
ORDINARY SHARES
3,250,0002,825,000-425,000$83.53M$57.83M4.38%-$25.70M
Janux Therapeutics, Inc.(JANX)2,100,0002,000,000-100,000$112.43M$54.00M4.09%-$58.43M
EyePoint, Inc.(EYPT)8,325,0008,325,0000$62.02M$45.12M3.42%-$16.90M
Insmed Incorporated(INSM)650,000525,000-125,000$44.88M$40.05M3.03%-$4.82M
Bright Minds Biosciences Inc.(DRUG)1,059,3311,059,3310$38.16M$38.21M2.89%+$53.0K
Helix Acquisition Corp IiCL A2,909,0002,909,0000$30.54M$32.87M2.49%+$2.33M
Centessa Pharmaceuticals PlcADS2,561,6002,261,600-300,000$42.91M$32.52M2.46%-$10.38M
Merus N V740,000740,0000$31.12M$31.15M2.36%+$29.6K
Rapport Therapeutics, Inc.(RAPP)2,940,9212,940,9210$52.17M$29.50M2.23%-$22.67M
Axsome Therapeutics, Inc.(AXSM)325,000250,000-75,000$27.50M$29.16M2.21%+$1.66M
Pharvaris N V
COM
1,466,4601,466,4600$28.11M$23.02M1.74%-$5.09M
GH Research PLC(GHRS)593,0432,009,482+1,416,439$4.15M$22.16M1.68%+$18.01M
Arcutis Biotherapeutics, Inc.(ARQT)1,825,0001,350,000-475,000$25.42M$21.11M1.60%-$4.31M
Tarsus Pharmaceuticals, Inc.(TARS)500,000400,000-100,000$27.68M$20.55M1.56%-$7.14M
ARS Pharmaceuticals, Inc.(SPRY)500,0001,600,000+1,100,000$5.28M$20.13M1.52%+$14.85M
Crinetics Pharmaceuticals In1,000,000600,000-400,000$51.13M$20.12M1.52%-$31.01M
CG Oncology, Inc.(CGON)775,000775,0000$22.23M$18.98M1.44%-$3.25M
Cargo Therapeutics Inc1,182,5633,381,277+2,198,714$17.05M$13.76M1.04%-$3.29M
ABIVAX Société AnonymeADS(ABVX)2,130,0002,130,0000$15.59M$13.31M1.01%-$2.28M
Alumis Inc2,147,3962,147,3960$16.88M$13.19M1.00%-$3.69M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)2,375,0002,375,0000$28.02M$12.61M0.95%-$15.41M
Avidity Biosciences Inc1,050,000400,000-650,000$30.53M$11.81M0.89%-$18.73M
Metsera Inc0400,000+400,000$0$10.89M0.82%+$10.89M
Engene Holdings Inc
COM
2,323,5952,323,5950$15.45M$10.41M0.79%-$5.04M
BioAge Labs, Inc.(BIOA)2,629,5292,629,5290$15.22M$9.89M0.75%-$5.34M
Rhythm Pharmaceuticals, Inc.(RYTM)400,000150,000-250,000$22.39M$7.95M0.60%-$14.45M
OnKure Therapeutics, Inc.CL A(OKUR)1,837,7391,837,7390$15.80M$7.90M0.60%-$7.90M
Biomea Fusion, Inc.(BMEA)3,570,8723,570,8720$13.85M$7.61M0.58%-$6.25M
Korro Bio, Inc.(KRRO)0380,303+380,303$0$6.62M0.50%+$6.62M
Vaxcyte, Inc.(PCVX)425,000175,000-250,000$34.79M$6.61M0.50%-$28.18M
Aardvark Therapeutics Inc0800,189+800,189$0$6.01M0.45%+$6.01M
MBX Biosciences, Inc.(MBX)700,000700,0000$12.90M$5.17M0.39%-$7.74M
Enliven Therapeutics Inc250,000250,0000$5.63M$4.92M0.37%-$705.0K
Pliant Therapeutics, Inc.(PLRX)03,000,000+3,000,000$0$4.05M0.31%+$4.05M
KALA BIO, Inc.(KALA)603,027603,0270$4.19M$3.46M0.26%-$729.7K
Stoke Therapeutics, Inc.(STOK)254,161254,1610$2.80M$1.69M0.13%-$1.11M
Biohaven Ltd.(BHVN)55,53910,000-45,539$2.07M$240.4K0.02%-$1.83M
ArriVent BioPharma, Inc.(AVBP)585,4620-585,462$15.60M$0—-$15.60M
Artiva Biotherapeutics, Inc.(ARTV)103,6330-103,633$1.04M$0—-$1.04M
ImmunityBio, Inc.(IBRX)3,000,0000-3,000,000$7.68M$0—-$7.68M
Omeros Corporation(OMER)300,0000-300,000$2.96M$0—-$2.96M
Rapt Therapeutics Inc200,0000-200,000$316.0K$0—-$316.0K
Septerna, Inc.(SEPN)560,0000-560,000$12.82M$0—-$12.82M
UroGen Pharma Ltd.(URGN)300,0000-300,000$3.19M$0—-$3.19M
Verve Therapeutics Inc350,0000-350,000$1.97M$0—-$1.97M
Yarrow Bioscience Inc(YARW)1,394,3360-1,394,336$4.67M$0—-$4.67M
Y-Mabs Therapeutics Inc425,0000-425,000$3.33M$0—-$3.33M
Page 1 of 1